Both in Pharmaceuticals
Ironwood Pharmaceuticals, Inc. - vs Bicara Therapeutics
Over the past year IRWD returned +133.3% and BCAX returned −44.5%; their daily moves had a correlation of 0.09.
IRWD +133.3% BCAX −44.5%Growth of $1, one year, split-adjusted
| Metric | IRWD | BCAX |
|---|---|---|
| Price | $3.50 | $9.13 |
| Market cap | $578.3M | $604.2M |
| Today | −3.31% | −6.17% |
| 1 month | −6.9% | −49.8% |
| 6 months | −21.2% | −57.9% |
| Year to date | +3.9% | −45.8% |
| 1 year | +131.8% | −42.5% |
| Revenue growth (YoY) | +32.6% | — |
| Gross margin | 100.0% | — |
| Net margin | 45.4% | — |
| P/E (TTM) | 4.5× | — |
| Price / sales | 1.5× | — |
| Net cash | -$305.9M | $497.3M |
| Dividend yield | — | — |
| Volatility (60d) | 50.3% | 129.5% |
| Short % of float | 10.6% | 23.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).